Chronic rhinosinusitis with nasal polyps (CRSwNP) treated with omalizumab, dupilumab, or mepolizumab: A systematic review of the current knowledge towards an attempt to compare agents' efficacy.
Papacharalampous GX, Constantinidis J, Fotiadis G, Zhang N, Bachert C, Katotomichelakis M.
Int Forum Allergy Rhinol. 2024 Jan;14(1):96-109. doi: 10.1002/alr.23234. Epub 2023 Jul 18.
PMID:37394893
Dupilumab Versus Mepolizumab for Chronic Rhinosinusitis With Nasal Polyposis: An Indirect Treatment Comparison.
Hopkins C, Han JK, Fokkens W, Wagenmann M, Guyot P, Khan AH, Nash S, Wang Z, Xu Y, Msihid J, Neupane B, Nag A, Bachert C.